Shelton Carolyn Hamby 5
5 · Nexalin Technology, Inc. · Filed Feb 10, 2025
Insider Transaction Report
Form 5
Shelton Carolyn Hamby
Sr. VP - Quality, Regulatory
Transactions
- Purchase
Common stock
2024-10-14$0.85/sh+24,000$20,400→ 24,000 total - Award
Stock Option (right to buy)
2024-11-07+90,620→ 90,620 totalExercise: $0.66Exp: 2029-09-25→ Common Stock (90,620 underlying)
Holdings
- 24,000
Common stock
Footnotes (2)
- [F1]Represents shares purchased after appointment as Senior Vice President, Quality, Regulatory and Clinical Affairs.
- [F2]The reporting person was granted an option to purchase 90,620 shares of common stock. The option vests in three equal annual installments based on the satisfaction of certain performance criteria for each of the annual periods ending September 16, 2025, 2026 and 2027.